Pancreas B&B Flashcards

1
Q

where are beta, alpha, and delta cells anatomically located in the pancreas?

A

beta cells (insulin) centrally located, most abundant

alpha (glucagon) and delta (somatostatin) cells found in outer islets surrounding beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe the process of insulin secretion from beta cells of the pancreas (3 steps)

A
  1. synthesized as preproinsulin in RER
  2. cleaved to proinsulin and transported to Golgi
  3. packaged into secretory granules and cleaved to insulin + C-peptide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the structure of insulin

A

alpha chain + beta chain, connected via disulfide bridges

C-peptide (“connecting”) initially connects alpha/beta chains but is cleaved from proinsulin… has a long half life and can be measured as indication of insulin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe the mechanism of insulin release from pancreatic beta cells (3 steps)

A
  1. glucose enters via GLUT-2, leading to ATP production
  2. increased ATP causes K+ channels to close (K+ is trapped within cell), triggering depolarization
  3. depolarization causes voltage-gated Ca2+ channels to open, triggering exocytosis of stored insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the effect of epinephrine on beta cells of the pancreas?

A

acts on beta-2 receptors to increase insulin release

acts on alpha-2 receptors to decrease insulin release - this is the dominant effect

net: increase plasma glucose during fight/flight response (overall decrease insulin release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which glucose transporter is bidirectional?

A

GLUT-2: bidirectional

found in liver, kidney, pancreatic beta cells - allows for regulation of blood glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the steps of insulin receptor activation, and the 2 possible outcomes?

A
  1. insulin binds, triggering autophosphorylation of tyrosine kinase domains
  2. IRS (insulin receptor substrates) mediate downstream effects
    3a. PIK3 pathway forms PIP3 —> increase GLUT-4 expression
    3b. RAS/MAPK activation (G protein) —> modify cell growth/ gene expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does insulin lead to the increase in GLUT-4 expression?

A

insulin binds tyrosine kinase receptor, which downstream forms PIP3 —> this catalyzes increase in GLUT-4 expression on cell surfaces

GLUT-4 stored in vesicles, esp. important for glucose uptake in muscle and fat … it makes sense that you want this to be really responsive to insulin levels !

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe why muscle and fat are referred to as insulin-dependent organs, while brain and RBC are insulin-independent

A

muscle/fat use GLUT-4 for glucose uptake - surface expression depends on insulin receptor activation and downstream formation of PIP3

brain/RBC use GLUT-1 for glucose uptake, which takes up glucose whenever it is available (RBC has no mitochondria, brain has not fatty acid metabolism - these tissues rely on glucose/glycolysis)

liver/kidney/intestines are also insulin dependent, via GLUT-2 (bidirectional)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which enzymes does insulin activate or inhibit to have the following metabolic effects?
a. increase glycogen synthesis
b. inhibit gluconeogenesis
c. increase fatty acid synthesis

A

a. increase glycogen synthesis - activates glycogen synthase, inhibits glycogen phosphorylase

b. inhibit gluconeogenesis - inhibits fructose-1,6-bisphosphatase 1 (F-1,6-B1)

c. increase fatty acid synthesis - activates acetyl-CoA carboxylase, inhibits hormone sensitive lipase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

explain why glucose + insulin is used for the treatment of hyperkalemia

A

insulin lowers serum K+ by enhancing Na/K/ATPase pumps in skeletal muscle (recall insulin causes K+ channels to close)

must give with glucose to prevent hypoglycemia with insulin administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

on what tissues does glucagon exert its effects? what are its effects (4)?

A

works on liver mostly (NO receptors in muscle)

  1. glycogen breakdown
  2. increases gluconeogenesis
  3. amino acid uptake (more carbon skeletons for glucose via gluconeogenesis)
  4. activates lipolysis via hormone sensitive lipase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what signaling pathway is activated by glucagon receptors?

A

glucagon (protein hormone, single polypeptide chain) binds glucagon receptor (GPCR) —> adenylyl cyclase —> cAMP —> PKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the 2 clinical uses of glucagon administration?

A
  1. hypoglycemia in unconscious patient
  2. beta blocker overdose - raises intracellular cAMP like beta-adrenergic receptors do, but via binding glucagon receptors (getting around the fact that the beta receptors are blocked)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the top 2 treatments of choice for hypoglycemia in an unconscious patient? (can’t feed them cookies)

A
  1. IV dextrose
  2. intramuscular glucagon - useful when IV cannot be established
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

explain how glucagon can be used to treat beta blocker overdose

A

beta blocker overdose causes bradycardia and hypotension

DOC: glucagon - activates adenylyl cyclase, increase cAMP —> increased myocyte calcium

same mechanism as beta-adrenergic stimulation, but via glucagon receptor, getting around the fact that they beta receptors are blocked (duh)

17
Q

what is the drug of choice for beta blocker overdose?

A

beta blocker overdose causes bradycardia and hypotension

DOC: glucagon - activates adenylyl cyclase, increase cAMP —> increased myocyte calcium

same mechanism as beta-adrenergic stimulation, but via glucagon receptor, getting around the fact that they beta receptors are blocked (duh)

18
Q

how does an insulinoma present?

A

insulinoma: rare pancreatic islet-cell tumor which secretes insulin

presents in adults (~50) with fasting hypoglycemia and “neuroglycopenic symptoms” (confusion, odd behavior)

also SNS activation in response to low glucose - palpitations, diaphoresis, tremor

19
Q

what is the differential diagnosis for fasting hypoglycemia and how is diagnosis made?

A
  1. exogenous insulin - high serum insulin only
  2. insulinoma - high insulin + C peptide
  3. oral hypoglycemics such as sulfonylureas - high insulin + C peptide + drug screen

[recall C peptide is “connector” between alpha/beta insulin subunits, which gets cleaved off]

20
Q

Pt is a 51yo F presenting with confusion, odd behavior, palpitations, and diaphoresis. Labs show fasting hypoglycemia and elevated C peptide. What is the likely diagnosis?

A

insulinoma: rare pancreatic islet-cell tumor which secretes insulin

presents in adults (~50) with fasting hypoglycemia and “neuroglycopenic symptoms” (confusion, odd behavior)

also SNS activation in response to low glucose - palpitations, diaphoresis, tremor

21
Q

how do glucagonomas present? (3 things)

A

rare pancreatic tumors secreting glucagon —> glucose intolerance, presenting like diabetes (elevated fasting glucose levels) but WITHOUT diabetic ketoacidosis (DKA) because insulin function is intact

also presents with weight loss (constant gluconeogenesis in liver is consuming calories) and necrolytic migratory erythema rash (genitals, buttocks, groin)

22
Q

a patient is presenting with elevated fasting glucose levels - how could you distinguish if the patient has diabetes or a glucagonoma? (in theory)

A

diabetic ketoacidosis (DKA) will NOT occur with a glucagonoma because insulin function is intact

23
Q

new onset of diabetes + unexplained rash =

A

glucagonoma: rare pancreatic tumor secreting glucagon

presents with elevated fasting glucose, weight loss, necrolytic migratory erythema rash (genitals, buttocks, groin)

24
Q

Pt is a 46yo M presenting with recent weight loss and development of a red, blistering rash on their buttocks which is itchy and painful. Labs show elevated fasting glucose. What is the likely diagnosis?

A

glucagonoma: rare pancreatic tumor secreting glucagon

presents with elevated fasting glucose, weight loss, necrolytic migratory erythema rash (genitals, buttocks, groin)

new diabetes + rash = glucagonoma

25
Q

what is the treatment for glucagonoma?

A

tx: somatostatin analogs (octreotide) - inhibit glucagon secretion

26
Q

what are MEN syndromes, and more specifically what are MEN Type 1?

A

MEN (multiple endocrine neoplasia): rare inherited disorders of numerous endocrine tumors

MEN Type 1: insulinomas/glucagonomas via mutation in MEN1 tumor suppressor gene; 3 Ps: pituitary, parathyroid, pancreas effected